Back to search

Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly

Data up to Jan 2025

Published2003
Citations212
References19

Total Citations Per Year

Abstract

References (19)

Clinical Applications of Research on Angiogenesis

1995 • 2,300 citations

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

2000 • 1,536 citations

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1990 • 1,308 citations

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2000 • 1,159 citations

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.

1993 • 1,086 citations

Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice

1999 • 990 citations

Tumor angiogenesis: past, present and the near future

2000 • 973 citations

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

1999 • 866 citations

The microtubule-affecting drug paclitaxel has antiangiogenic activity.

1996 • 643 citations

Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.

1997 • 525 citations

Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene

1990 • 452 citations

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agents

1991 • 441 citations

The Ras superfamily of GTPases 1

1996 • 269 citations

A Novel, Microcarrier-Based in Vitro Assay for Rapid and Reliable Quantification of Three-Dimensional Cell Migration and Angiogenesis

1995 • 244 citations

‘Accidental’ anti-angiogenic drugs

2000 • 181 citations

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanism

1991 • 175 citations

Paclitaxel (Taxol): An Inhibitor of Angiogenesis in a Highly Vascularized Transgenic Breast Cancer

1999 • 169 citations

Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases

2000 • 95 citations

Antiangiogenic chemotherapeutic agents.

2000 • 40 citations

Cited By (0)

Loading...
Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular… (2003) – Anti-Cancer Drugs | Metascience Observatory Explorer